Sun Pharma Q1 Results: Sun Pharma’s revenue from operations in Q1FY25 increased 6% to ₹12,652.7 crore from ₹11,940.84 crore, YoY. US Formulation sales fell 1% to $466 million and accounted for over 31.1% of total consolidated sales. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
